T-Cadherin Expression in Cardiac Allograft Vasculopathy after Human Heart Transplantation

被引：0
|
作者：
Roussoulieres, A. [1 ,2 ]
Collot-Teixeira, S. [3 ]
Morser, K. [3 ]
Chalabreysse, L. [4 ]
McDermott-Roe, C. [3 ]
Cerutti, C. [2 ]
Guzman, A. [5 ]
Michel, J-B [5 ]
Boissonnat, P. [1 ]
Sebbag, L. [1 ]
Thivolet-Bejui, F. [4 ]
Bricca, G. [2 ]
McGregor, J. [3 ,5 ]
机构：
[1] Hop Cardiovasc & Pneumol Louis Pradel, Lyon, France
[2] Univ Lyon 1, INSERM, F-69365 Lyon, France
[3] Kings Coll London, London WC2R 2LS, England
[4] Hop Cardiovasc & Pneumol Louis Pradel, Lyon, France
[5] Hop Lariboisiere, INSERM, F-75475 Paris, France
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2009年 / 28卷 / 02期
关键词：
D O I：
10.1016/j.healun.2008.11.816
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
138
引用
收藏
页码：S113 / S114
页数：2
相关论文
共 50 条
  • [1] T-cadherin expression in cardiac allograft vasculopathy: Bench to bedside translational investigation
    Collot-Teixeira, Sophie
    McGregor, John L.
    Morser, Kira
    Chalabreysse, Lara
    McDermott-Roe, Chris
    Cerutti, Catherine
    Guzman, Adriana
    Michel, Jean-Baptiste
    Boissonnat, Pascale
    Sebbag, Laurent
    Thivolet-Bejui, Francoise
    Bricca, Gianpiero
    Obadia, Jean-Francois
    Roussoulieres, Ana
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (07): : 792 - 799
  • [2] DYSLIPIDEMIA AND CARDIAC ALLOGRAFT VASCULOPATHY AFTER HEART TRANSPLANTATION
    Simonenko, M.
    Sazonova, Y.
    Fedotov, P.
    Krasnov, V.
    Rubinchik, V.
    Pervunina, T.
    Berezina, A.
    Privorotskii, V.
    Zverev, D.
    Sitnikova, M.
    Nikolaev, G.
    Gordeev, M.
    Karpenko, M.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 11 - 11
  • [3] OBESITY AND CARDIAC ALLOGRAFT VASCULOPATHY AFTER HEART TRANSPLANTATION
    Carr, S.
    Hamilton, M.
    Kobashigawa, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (01) : 158 - 158
  • [4] Expression of iNOSmRNA to prevent cardiac allograft vasculopathy after heart transplantation in rat
    吴乃石
    藏旺福
    张科峰
    张明宇
    姚志发
    ChinaMedicalAbstracts, 2005, (04) : 293 - 296
  • [5] Cardiac allograft vasculopathy after heart transplantation: Is it really ominous?
    Lim, Ju Yong
    Jung, Sung Ho
    Kim, Min Seok
    Park, Jeong-Jun
    Yun, Tae-Jin
    Kim, Jae Joong
    Lee, Jae Won
    CLINICAL TRANSPLANTATION, 2017, 31 (02)
  • [6] Accelerated cardiac allograft vasculopathy after pediatric heart transplantation
    Zablah, Jenny E.
    Everitt, Melanie D.
    Wilson, Neil
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (11) : 2984 - 2985
  • [7] PET Assessment of Cardiac Allograft Vasculopathy After Heart Transplantation
    Asleh, Rabea
    Kushwaha, Sudhir S.
    JACC-HEART FAILURE, 2023, 11 (05) : 566 - 568
  • [8] Factors associated with the cardiac allograft vasculopathy after heart transplantation
    Szczurek, W.
    Gasior, M.
    Skrzypek, M.
    Romuk, E.
    Zembala, M.
    Jurkiewicz, B. Szygula
    EUROPEAN HEART JOURNAL, 2020, 41 : 2697 - 2697
  • [9] The pharmaceutical management of cardiac allograft vasculopathy after heart transplantation
    Spitaleri, Giosafat
    Farrero Torres, Marta
    Sabatino, Mario
    Potena, Luciano
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (11) : 1367 - 1376
  • [10] Factors associated with cardiac allograft vasculopathy after heart transplantation
    Szczurek-Wasilewicz, Wioletta
    Hawranek, Michal
    Skrzypek, Michal
    Hrapkowicz, Tomasz
    Gasior, Mariusz
    Warmusz, Oliwia
    Szygula-Jurkiewicz, Bozena
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2022, 18 (03): : 237 - 245
12345